Bioinformatics-Based Identification of HDAC Inhibitors as Potential Drugs to Target EGFR Wild-Type Non-Small-Cell Lung Cancer

Overview of attention for article published in Frontiers in oncology, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 6 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 7,420 followers.

New research: Bioinformatics-Based Identification of HDAC Inhibitors as Potential Drugs to Target EGFR Wild-Type Non-Small-Cell Lung Cancer: Patients with EGFR-mutant non-small-cell lung cancer (NSCLC) greatly benefit from EGFR-tyrosine kinase… https://t.c

14 Apr 2021

Reply Repost Favourite

New article: Bioinformatics-Based Identification of HDAC Inhibitors as Potential Drugs to Target EGFR Wild-Type Non-Small-Cell Lung Cancer https://t.co/iPGwsVl1eW #lungcancer #oncology https://t.co/UdIBXj6qhe

25 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.